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In the beginning of the twenty-first century, humanity faces great challenges regarding
diseases and health-related quality of life. A drastic rise in bacterial antibiotic resistance,
in the number of cancer patients, in the obesity epidemics and in chronic diseases
due to life expectation extension are some of these challenges. The discovery of novel
therapeutics is fundamental and it may come from underexplored environments, like
marine habitats, and microbial origin. Actinobacteria are well-known as treasure chests
for the discovery of novel natural compounds. In this study, eighteen Actinomycetales
isolated from marine sponges of three Erylus genera collected in Portuguese waters
were tested for bioactivities with the main goal of isolating and characterizing
the responsible bioactive metabolites. The screening comprehended antimicrobial,
anti-fungal, anti-parasitic, anti-cancer and anti-obesity properties. Fermentations of
the selected strains were prepared using ten different culturing media. Several
bioactivities against the fungus Aspergillus fumigatus, the bacteria Staphylococcus
aureus methicillin-resistant (MRSA) and the human liver cancer cell line HepG2 were
obtained in small volume cultures. Screening in higher volumes showed consistent anti-
fungal activity by strain Dermacoccus sp. #91-17 and Micrococcus luteus Berg02-26.
Gordonia sp. Berg02-22.2 showed anti-parasitic (Trypanosoma cruzi) and anti-cancer
activity against several cell lines (melanoma A2058, liver HepG2, colon HT29, breast
MCF7 and pancreatic MiaPaca). For the anti-obesity assay, Microbacterium foliorum
#91-29 and #91-40 induced lipid reduction on the larvae of zebrafish (Danio rerio).
Dereplication of the extracts from several bacteria showed the existence of a variety
of secondary metabolites, with some undiscovered molecules. This work showed that
Actinomycetales are indeed good candidates for drug discovery.
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INTRODUCTION
The technological advances made in the twenty and twenty-
first centuries gave rise to the most prosperous society
which has ever existed (International Monetary Fund Research
Department [IMF], 2000). This well-being is associated with
an overall drastic increase in the average life expectancy
(Vaupel, 2010) and with several problems faced by the
today’s society. One of these problems is a result of the
increase in caloric uptake and lack of exercise which results
in an epidemic of overweight. Obese people present major
challenges, as obesity entails a myriad of risk factors for
chronic diseases like diabetes, heart diseases and even some
cancers (Hruby and Hu, 2015). Furthermore, the extended life
span associated with environmental factors such as tobacco
smoking, industrialization and urbanization are causes behind
the increase in cancer incidence rates (You and Henneberg,
2018). Antibiotic resistance is another emerging problem.
Overabundance in the use of antibiotics as well as their intense
misuse resulted in the phenomenon of antibiotic resistance,
which is rapidly occurring worldwide, with many commonly
used antibiotics having already been rendered useless (Ventola,
2015). Several are thus the challenges at the beginning of the
twenty-first century.
In recent years, research into new compounds has been
focused in the ocean and many marine organisms are proving
to be good sources of interesting new leads (Imhoff et al.,
2011) Drugs like xestospongin C and several manoalides were
discovered in marine animals like sponges (Miyamoto et al.,
2000; Stowe et al., 2011). Sponges have a diverse microbiological
community, often showing the presence of archaea, fungi,
microalgae and a great diversity of bacterial phyla (Taylor
et al., 2007). While sponges are good candidates for drug
discovery, a major setback is that sponges may only contain
minute quantities of these compounds in their body, which
may invalidate clinical trials (Mehbub et al., 2014). However,
it seems that the symbiotic microbiological community is the
true origin of several relevant compounds (Yoo Kyung et al.,
2001). It is also known that Actinobacteria are copious producers
of bioactive metabolites. Particularly prolific are species isolated
from soil and affiliated to the Actinomycetales, most notably the
genus Streptomyces (Miao and Davies, 2010). Less studied are
marine Actinobacteria which have nonetheless already shown
potential as sources for novel leads. Several bioactive molecules,
ranging from antimalarians like salinipostins, cytotoxics such as
marinomycins to antibacterials as abyssomicins, have all been
isolated from Actinobacteria found in marine environments
(Bister et al., 2004; Kwon et al., 2006; Schulze et al., 2015;
Dhakal et al., 2017).
This study aimed to contribute to the need of finding new
and more effective bioactive molecules against several of the
earlier mentioned threats faced by human kind nowadays.
For this, eighteen species from the Actinomycetales previously
isolated from Erylus spp. sponges collected in Portuguese
marine waters (Açores, Madeira, and continental shelf) were
screened for antimicrobial, anti-cancer, anti-parasitic and anti-
obesogenic activities.
MATERIALS AND METHODS
Biological Material
The bacteria under study belong to the order Actinomycetales
within the phylum Actinobacteria and were isolated from marine
sponges of the genus Erylus, E. discophorus (Berg01 and Berg02,
from the continental shelf at Berlengas, Portugal) and E. deficiens
(#91, from the continental shelf at Gorringe, Portugal) and
E. mamillaris (SM, Açores, Portugal) (Table 1). Most of these
strains showed the presence of interesting secondary metabolism
genes and/or bioactivities in previous antimicrobial screenings
(Table 1; Graca et al., 2013, 2015).
For the antimicrobial assays six different pathogens were
tested, Escherichia coli ATCC25922 (EcoWT), Klebsiella
TABLE 1 | List of Actinomycetales used in this study evidencing their physiological
affiliation and bioactive potential.
Strain ID Affiliation Secondary
metabolism gene
Previous
bioactivity
#91_17∗ Dermacoccus sp. Ellin185;
AF409027
NRPS CA
#91_20 Rhodococcus hoagii CUB1156;
AJ272469
N/D NA
#91_29∗ Microbacterium foliorum
BJC15-C14; JX464206
N/D CA
#91_31∗ Microbacterium
hydrocarbonoxydans 3084;
EU714352
N/D CA
#91_34∗ Microbacterium
esteraromaticum 2122;
EU714337
N/D CA
#91_35∗ Microbacterium phyllosphaerae
(T); DSM 13468; P 369/06;
AJ277840
PKS-I CA; VA
#91_36.1∗ Rhodococcus equi type strain:
DSM20307; X80614
PKS-I; NRPS CA; VA; EC
#91_37∗ Microbacterium foliorum
BJC15-C1; JX401513
N/D CA; VA
#91_40∗ Microbacterium foliorum
BJC15-C14; JX464206
PKS-I CA; VA
#91_44 Rhodococcus sp. PKS-I; NRPS NA
#91_54 Rhodococcus qingshengii
KUDC1814; KC355321
NRPS CA, VA
SM 115 Agrococcus baldri B-G-NA10 PKS-I NA
SM 116 Agrococcus baldri B-G-NA10 PKS-I NA
Berg01-119c Microbacterium sp. ZJY-409 N/D VA; VF
Berg02-22.2∗ Gordonia sp. DEOB200;
AY927227
PKS-I BS
Berg02-26 Micrococcus luteus; KCL-1;
DQ538135
N/D NA
Berg02-78∗ Gordonia terrae 3269aBRRJ;
FJ200386
PKS-I; NRPS BS
Berg02-79∗ Microbacterium sp. M63-2;
EF061897
N/D BS
∗Strains assayed for anti-obesity; PKS-I, Polyketide Synthase I; NRPS, Non-
ribosomal Peptide Synthetases; N/D, Not determined; NA, No Activity; CA,
Candida albicans; BS, Bacillus subtilis; EC, Escherichia coli; VA, Vibrio anguillarum;
VF, Vibrio fisheri.
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pneumoniae ATCC 700603, Methicillin-resistant Staphylococcus
aureus MB5393 (MRSA), Staphylococcus aureus ATCC29213
(MSSA), Acinetobacter. baumannii MB5973 Aspergillus
fumigatus ATCC46645, and Candida albicans ATCC64124.
For the anti-cancer assays the following cell lines were tested:
human melanoma (A2058), human lung carcinoma (A549),
human hepatocellular carcinoma (HepG2), human colon cancer
(HT29), human breast cancer (MCF7), and human pancreatic
cancer (MIA PaCa-2). Anti-parasitic activity was assessed using
the parasite Trypanosoma cruzi Tulahuen C4 strain. As T. cruzi
is an obligate intracellular parasite, it was cultivated inside host
L6 rat skeletal muscle cells. Anti-obesogenic activity was tested
using the zebrafish (Danio rerio) larvae.
Growth Media
The various Actinomycetales were cultivated and maintained
in Marine Agar (MA) medium (Graca et al., 2013, 2015) at
25◦C in darkness.
To conduct the screenings, liquid fermentations of the
strains were prepared, using ten different culturing media.
These different media provide a range of nutritional conditions
(from oligotrophic to heterotrophic status) aiming to favor the
production of bioactive metabolites. These include several ready
prepared media such as Antibiotic Broth (AB) (1.0 g/L dextrose,
3.68 g/L K2HPO4, 1.5 g/L meat extract, 5.0 g/L peptone, 1.32 g/L
KH2PO4, 3.5 g/L NaCl and 1.5 g/L yeast extract), Tryptic Soy
Broth (TSB) (17 g/L tryptone, 3 g/L phytone, 5 g/L NaCl,
2.5 g/L K2HPO4 and 2.5 g/L glucose) and Marine Broth (MB)
(5 g/L peptone, 1 g/L yeast extract, 40 g/L sea salts) CGY (Rojas
et al., 2009), DEF-15 (Lam et al., 1995), IN-CRY (Obata et al.,
1999), R358 (Jensen et al., 2007), and other media specified in
Table 2. Moreover, as all the strains were previously isolated
from a marine environment, Sea salts (Sigma-Aldrich) were
added to all the media at a concentration of 30 g/L, except
in the medium MB.
Extraction Protocols
Small Scale-Culture Extraction
A first small-scale fermentation in 0.8 mL cultures was
performed. Bacterial strains were grown in the 10 media in 96-
well plates (Duetz system1) (Duetz et al., 2000; Minas et al.,
2000; Duetz, 2007; Palomo et al., 2013; Pan et al., 2019) for 5
days at 25◦C, 20% humidity and 300 revolutions per minute
(rpm). After incubation, 0.8 mL acetone were added to each
bacterial culture. The acetone/culture mixture was mixed for
1 h at 170 rpm and later evaporated up to a final volume of
0.6 mL in a Genevac R© centrifugal evaporator. Due to a large
presence of salts that might influence subsequent assays, the
0.6 mL were captured in a WatersTM Oasis R© HLB extraction
plates, with the sorbent Oasis R© HLB. The Oasis R© HLB plate
was equilibrated using first methanol and after HPLC grade
water. The extract was run though the Oasis R© HLB plate in
0.2 mL steps, vacuum-eluted and the collected volume discarded.
Subsequently, the secondary metabolites were captured with
methanol. The methanol was, then removed in a Genevac R© and
1www.enzyscreen.com
TABLE 2 | Composition of the media used for liquid culture extractions.
Reagents (g/L) Medium
FPY-12 M016 R2A
Yeast Extract – 1.0 5.0∗ 10−1
Casein hydrolysate – – 5.0∗ 10−1
Glucose 10 10 5.0∗ 10−1
Fructose 20 – –
Maltose 10 10 –
Peptone 5 – 5.0∗ 10−1
Amicase 5 – –
Starch – 10 5.0∗ 10−1
Soytone – 5.0 –
Tryptone – 4.0 –
K2HPO4 – 2.0∗ 10−1 3.0∗ 10−1
NaCl – 2.0∗ 10−2 –
KCl – 2.0∗ 10−5 –
MgSO4.7H2O – 5.0∗ 10−2 4.0∗ 10−2
KH2PO4 – 1.0∗ 10−1 –
CaCl2.H2O – 5.0∗ 10−2 –
C3H3NaO3 – – 3.0∗ 10−1
FeSO4.7H2O 5.0∗ 10−4 – –
ZnCl2 – 2.0∗ 10−5 –
ZnSO4.7H2O 5.0∗ 10−4 – –
MnSO4.H2O 1.0∗ 10−4 1.0∗ 10−4 –
CuSO4.5H2O 5.0∗ 10−5 – –
CoCl2.6H2O 5.0∗ 10−5 2.0∗ 10−5 –
SnCl2.2H2O – 5.0∗10−6 –
H3BO3 – 1.0∗ 10−5 –
Na2MoO4.2H2O – 1.2∗ 10−5 –
CuSO4 – 1.5∗ 10−5 –
FeCl3 – 5.8∗ 10−3 –
the recovered metabolites were dissolved in 0.4 mL 20% DMSO.
This allowed a twofold concentration increase of the extracts.
Additionally, as controls, culture media were also extracted with
the same protocol.
Medium-Scale Culture Extraction
Bacteria that showed bioactive extracts were re-fermented in
higher volumes (EPA vials system – 40 mL). Ten milliliters
of bacterial cultures were grown for 5 days at 25◦C with 20%
humidity and 220 rpm. After the 5 days period, 10 mL acetone
were added (1:1) to each culture and mixed for 1 h. The
acetone/culture mixture was then evaporated under nitrogen to
9 milliliters to remove all traces of acetone. To remove the salt
contamination, the resin SEPABEADS R© SP207ss was used. Two
milliliters of a ready prepared suspension of SP207ss were added
to the culture and mixed for 1 h. The vials were then centrifuged,
and the supernatant discarded. The resin was washed with HPLC
water. Ten mL of acetone were added to the resin, centrifuged
and the acetone was collected, evaporated under nitrogen and
dissolved in 2 mL of 20% DMSO. A fivefold increase of the
extracts was achieved. As controls, media samples were also
extracted with the same protocol.
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Anti-obesogenic Assays Culture Extraction
To test possible anti-obesity compounds produced by the selected
strains, each strain was grown in 100 mL Marine Broth at
25◦C, 200 rpm for 5 days. For the extraction, cell pellets were
lyophilized and mixed twice for 30 min with 50 mL methanol.
The collected methanol was dried in a rotatory evaporator and
the weight of the extract measured. The extracts were stored
at −20◦C and, when needed, dissolved in 100% DMSO at a
concentration of 10 mg/mL.
Bioactivity Assays
Antimicrobial Assays
Previously described methods using pathogenic microorganisms
from Fundación MEDINA’s collection were performed to test
for antibacterial and antifungal properties (Monteiro et al.,
2012; Audoin et al., 2013). Briefly, single colonies of each
microorganism were incubated overnight at 37◦C and 220 rpm
in their corresponding medium and then diluted in order to
obtain assay inoculum of approximately 1.1 × 106 CFU/mL
for methicillin-resistant S. aureus MB 5393, 5.0 × 105 CFU/mL
for A. baumannii MB5973, E. coli ATCC 25922, K. pneumoniae
ATCC 700603 and S. aureus ATCC 29213 and 2.5× 104 CFU/mL
for A. fumigatus ATCC46645. For C. albicans, the OD at 660 nm
of the liquid culture was adjusted to 0.25 and diluted 1:100
for assay inoculum.
For all the assays 90 µL/well of the corresponding diluted
inoculum were mixed with 10 µL/well of extract. Positive and
negative internal plate controls were included following the
previously described methodologies. Absorbance or fluorescence
were measured with an Envision plate reader. Genedata Screener
software (Genedata, Inc., Basel, Switzerland) was used to
analyze the data and to calculate the percentage of growth
inhibition of the extracts and the RZ’ factor to estimate
the robustness of the assays (Zhang et al., 1999). In all
experiments performed in this work, the RZ’ factor obtained was
between 0.87 and 0.92.
Anti-cancer Assays
The cytotoxic bioactivity of the extracts was tested by using the
portfolio of HTS assays from MEDINA according to Cautain
et al. (2015). Cytotoxic activity of the extracts (5 µL in 19 µL
medium) was tested against human hepatocellular carcinoma
(HepG2) for Duetz extracts and against human melanoma
(A2058), human lung carcinoma (A549), human hepatocellular
carcinoma (HepG2), human colon cancer (HT29), human breast
cancer (MCF7), and human pancreatic cancer (MIA PaCa-2) for
EPA vials extracts.
Anti-parasitic Assays
Anti-parasitic bioactivity of the extracts (5 µL of 1:1500
dilution) was tested against T. cruzi Tulahuen C4 strain
according to Annang et al. (2015).
Anti-obesogenic Assays
The anti-obesity activity of the extracts taken from 11 strains
arbitrarily chosen (Table 1) was tested using zebrafish larvae
as described in Urbatzka et al. (2018). Briefly, hatched larvae
were transferred to 48-well plates, 6–8 individual larvae per
well, with 750 µL water and N-phenylthiourea. Larvae were
then treated with 10 µg/mL extracts or 0.1% DMSO or
50 µM Resveratrol for 48 h. At 24 h, the solutions in
the wells were renewed and 10 ng/ml Nile red added. For
imaging, the larvae were anesthetized with 0.03% tricaine,
fluorescence intensity acquired in a fluorescence microscope
(Leica DM6000B) and the images analyzed with the software
ImageJ. Statistical significance was evaluated with an ANOVA
and Dunnett’s test.
Dereplication
Dereplication of the extracts was performed by Liquid
Chromatography/High-Resolution Mass Spectroscopy
(LC/HRMS) which was performed in an Agilent 1200
Rapid Resolution HPLC interfaced to a Bruker maXis mass
spectrometer. The column used for separation was a Zorbax SB-
C8 column (2.1× 30 mm, 3.5 mm particle size), with two solvents
used for the mobile phase. Both solvents were composed of water
and acetonitrile in a 90:10 ratio for solvent A and in a 10:90 ratio
for B. Both solvents contained 13 mM ammonium formiate and
0.01% trifluoracetic acid. The mass spectrometer was operated
in positive ESI mode. The retention time and exact mass of
the components were compared against Fundación MEDINA’s
high resolution mass spectrometry database, and when a match
was obtained it was reported as a named compound. For the
components with no matches in the MEDINA database, the
predicted molecular formula and exact mass were searched
for in the Chapman and Hall Dictionary of Natural Products
database. If a plausible match was found, considering the exact
mass/molecular formula, the producing microorganism and the
target assay, the molecule was reported as a suggested component
of the fraction (Perez-Victoria et al., 2016).
RESULTS
Small-scale extracts (0.8 mL cultures, performed in Duets plates)
are useful for a rapid evaluation of the bioactive profile of the
strains. However, due to the small volume of the extracts, only
a limited number of assays could be performed. For this reason,
only the antimicrobial and anti-parasitic assays were run with the
full number of targets, while in the anti-cancer assay, only the
HepG2 cell line was assayed. This cell line is used as a model
system for studies of liver toxicity (Mersch-Sundermann et al.,
2004) which is an important characteristic of the drugability
of any molecule.
From the 18 different strains tested in the 10 media, only 6
strains demonstrated bioactivity in one or more of the assays
performed (Table 3). Antifungal activity against A. fumigatus
ATCC46645 was obtained in several media with strains #91_17,
Berg02-26, Berg02-22.2, and Berg02-78. Strain Berg02-79 showed
activity against the methicillin-resistant S. aureus (MRSA) and
strains #91_40, Berg02-22.2 Berg02-78 and Berg02-79 were
effective against HepG2 cells. Berg02-78 extracts proved to be
bioactive against T. cruzi Tulahuen C4. As extracts from strains
#91_40, Berg02-22.2, Berg02-78, and Berg02-79 in medium
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IN-CRY proved to be hepatotoxic, no further testing was done
with these extracts.
With the medium scale extracts (10 mL culture – EPA
vials) and as the volume was no longer a limitation, all
microbiological, parasitic and cancer cell lines targets and
assays were tested. Antifungal activity against A. fumigatus
ATCC46645 and C. albicans ATCC64124 was obtained with
strains #91_17 (in media CGY and M016) and Berg02-26 (in
medium IN-CRY) (Table 4). Regarding the anticancer assays,
the extracts from AB medium of strain Berg02-22.2 showed
activity against human melanoma cell line (A2058), human
hepatocellular carcinoma cell line (HepG2), human colon cancer
cell line (HT29), human breast cancer cell line (MCF7), and
human pancreatic cancer cell line (MIA PaCa-2) (Table 4). No
TABLE 3 | Summary of the bioactivities obtained with the Duetz extracts.
Strain ID Affiliation Bioactivity
Target Medium % inhibition
or death
#91_17 Dermacoccus sp. AF CGY 66
IN-CRY 86
M016 60
#91_40 Microbacterium foliorum HepG2 IN-CRY 66
Berg02-22.2 Gordonia sp. AF AB 64
HepG2 IN-CRY 62
Berg02-26 Micrococcus luteus AF IN-CRY 69
R358 57
Berg02-78 Gordonia terrae AF AB 51
TC IN-CRY 50
Berg02-79 Microbacterium sp. MRSA R358 100
HepG2 IN-CRY 56
AF, A. fumigatus ATCC46645; CA, C. albicans ATCC64124; MRSA, Methicillin-
resistant S. aureus MB 5393; TC, T. cruzi Tulahuen C4.
TABLE 4 | Summary of the bioactivities obtained with the EPA extracts.
Strain ID Affiliation Bioactivity
Target Medium % inhibition
or death
#91_17 Dermacoccus sp. AF CGY 67
M016 93
CA CGY 82
M016 100
Berg02-22.2 Gordonia sp. TC AB 91
A2058 AB 71
HepG2 AB 88
HT29 AB 78
MCF7 AB 82
MIAPaCa-2 AB 72
Berg02-26 Micrococcus luteus AF IN-CRY 58
CA IN-CRY 75
AF, A. fumigatus ATCC46645; CA, C. albicans ATCC64124; MRSA, Methicillin-
resistant S. aureus MB 5393; TC, T. cruzi Tulahuen C4.
activity was observed against the human lung carcinoma cell
line (A549). Furthermore, strain Berg02-22.2 also showed anti-
parasitic activity against T. cruzi Tulahuen C4 (Table 4). With the
medium scale extracts, the bioactivities previously detected in the
small-scale extracts of strains Berg02-78 and Berg02-79 were not
confirmed (Tables 3, 4).
The results of the anti-obesity activity obtained are shown
in Figures 1, 2. Larvae incubated with only DMSO, the solvent
control of the experiment, showed an intense red fluorescent
staining which was considered as the 100% level of lipid content
(Figure 1B). As DMSO has low toxicity and does not affect
lipid accumulation on zebrafish larvae, as shown by Jones et al.
(2008), it is the commonly used solvent in the fish embryo
tests (Kais et al., 2013). When larvae were treated with final
concentration of 50 µM resveratrol, the positive control of
the experiment, a complete absence of red fluorescent staining
was visible (Figures 1D, 2) which is indicative of reduction of
lipid accumulation.
FIGURE 1 | Zebrafish larvae under brightfield (A,C,E,G) and fluorescence
microscopy (B,D,F,H). In (A,B) larvae were exposed only to DMSO, showing a
normal lipid buildup, situated mostly among the lower abdomen; in (C,D)
larvae were exposed to resveratrol, showing a decrease of neutral lipid
staining; in (E,F) larvae were exposed to extract from strain #91–40; in (G,H)
larvae were exposed to extract from strain #91-17. These larvae showed a
visible decrease and increase in fluorescence when compared to the DMSO
treated larvae, respectively. This implies that the extract altered the
accumulation of lipids in treated larvae.
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FIGURE 2 | Percentage of fluorescent staining of neutral lipids in zebrafish larvae. Values are presented as mean fluorescence intensity relative to the DMSO group in
a box-whisker plot. Statistical differences are represented as asterisks, ∗∗p < 0.01.
The zebrafish larvae treated with the majority of extracts
did not show different fluorescence levels compared to the
DMSO control. However, extracts from two strains, #91_29
and #91_40, reduced significantly the level of fluorescence
by 47% and 50% (Figures 1F, 2), respectively. The extract
from strain #91_17 induced a significant increase (43%) in
fluorescence levels (Figures 1H, 2). Statistical analysis showed
that these results are statistically different from the control
[F[19, 133] = 8.97; p < 0.01].
HPLC-HRMS results showed that the extract from strain
#91_17 (antifungal activity and increase in neutral lipids) has a
high complexity of already identified molecules (Table 5) which
are several diketopiperazines and the plant hormone indole
acetic acid (IAA). The four diketopiperazines identified in both
the extracts from media AB and M016 were cyclo(prolyltyrosyl),
cyclo([iso]leucylprolyl), cyclo(phenylalanylprolyl), and
cyclo(prolylvalyl). Moreover, four components with the
following formulae, C41H60N2O9, C43H64N2O9, C22H38N4O5,
and C22H21N3O3, were also identified in the extracts. These are
not described in the Chapman and Hall Dictionary of Natural
Products database.
In the extract from the AB medium of strain Berg02-
22.2 (antifungal in Duetz and antiparasitic and anticancer
activity in EPA vials), both Nocardichelin A (C40H65N5O8)
and B (C38H61N5O8) were found, as well as a component
with C42H69N5O8 as molecular formula and UV spectrum
and ionization pattern similar to both nocardachelins,
suggesting that this component is a new nocardachelin not
described previously (Figure 3). The peptide Gly-Pro-Phe-
Pro-Ile and the diketopiperazines cyclo([iso]leucylprolyl),
cyclo(phenylalanylprolyl) were also detected. Furthermore,
components with the formulae C52H74N10O11, C35H28N6O8,
C28H41N5O10 were found to be present.
The extract from the IN-CRY medium of strain Berg02-
26 (antifungal activity) showed the presence of two
diketopiperazines and two other compounds. Compound
C22H21N3O3 seems to be related to the diketopiperazine
cyclo(prolyltryrosyl), as the UV spectrum is similar. Component
C13H14N2O3 matches caerulomycin G in the DNP. However, the
UV spectrum is also similar to cyclo(prolyltryrosyl).
TABLE 5 | Dereplication of the selected active extracts.
Strain ID Culture
medium
Putatively detected components
#91_17 CGY Cyclo(prolyltyrosyl), cyclo([iso]leucylprolyl),
cyclo(phenylalanylprolyl), cyclo(prolylvalyl),
1H-indole-3-acetic acid, C41H60N2O9, and
C43H64N2O9.
#91_17 M016 Cyclo(prolyltyrosyl), cyclo([iso]leucylprolyl),
cyclo(phenylalanylprolyl), cyclo(prolylvalyl),
1H-indole-3-acetic acid, C22H38N4O5 and
C22H21N3O3
Berg02-22.2 AB Cyclo([iso]leucylprolyl), Cyclo(phenylalanylprolyl),
C52H74N10O11, C35H28N6O8, C28H41N5O10,
Gly-Pro-Phe-Pro-Ile peptide, nocardichelin A,
nocardichelin B and an undescribed
nocardichelin (C42H69N5O8).
Berg02-26 IN-CRY Cyclo([iso]leucylprolyl), cyclo(prolyltyrosyl)
C22H21N3O3 and C13H14N2O3 (coincidence with
caerulomycin G.)
Frontiers in Microbiology | www.frontiersin.org 6 April 2019 | Volume 10 | Article 727
fmicb-10-00727 April 9, 2019 Time: 14:19 # 7
Santos et al. Bioactivity of Actinomycetales From Sponges
FIGURE 3 | UV and mass spectra of (A) nocardichelin A and (B) component C42H69N5O8 detected in the extract from the AB medium of strain Berg02-22.2. The
comparison of the spectra shows the similarities between the two components which suggest that the component C42H69N5O8 is a new nocardichelin.
DISCUSSION
The selected strains under study all belong to the Actinomycetales,
an order that is known for the production of a great number
of useful secondary metabolites (Manivasagan et al., 2014; van
Keulen and Dyson, 2014; Barka et al., 2016). Although these
strains do not belong to the most prolific genera, Streptomyces
(Ser et al., 2015; Tan et al., 2016; Lee et al., 2018) or
Salinispora (Jensen et al., 2015), they hold great potential for
novel pharmaceutically relevant molecules. The strains here
studied were chosen based on previous molecular and screening
evidences of bioactive potential (Graca et al., 2013, 2015). As
evidenced in Table 1, many of the strains hold key genes
to produce secondary metabolites, like polyketide synthases
(PKS) and non-ribosomal peptide synthetases (NRPS) and
demonstrated antimicrobial bioactivity.
For an overall view of the results obtained, bioactivities and
extracts dereplication results are summarized in Table 6.
Our small-scale results not only confirmed the bioactive
potential seen previously but proved that several of the selected
strains possessed a variable repertoire of bioactivities (Table 3). In
the small-scale extraction results, Dermacoccus sp. strain #91_17
showed activity against A. fumigatus but not against C. albicans,
as had previously been shown (Graca et al., 2015). However, with
medium-scale extraction, C. albicans bioactivity was restored
(Table 4). Bioactive compounds have been discovered in
Dermacoccus genus. Dermacoccus nishinomiyaensis has displayed
the capability to produce monensins A and B, which are produced
in a classic polyketide pathway (AlMatar et al., 2017). Monensin
has been tested as a chelating agent for the treatment of lead
poisoning, with promising results in mice (Ivanova et al., 2016).
Phenazine-type pigments, dermacozines, have been isolated from
Dermacoccus abyssi. Dermacozines F and G have been shown
to induce moderate cytotoxic against leukemia cell line K562
(Manivasagan et al., 2014). Hence, Dermacoccus has shown
to be a genus with a good potential biotechnological value.
In this study, Dermacoccus sp. strain #91_17 did not display
any anti-cancer bioactivity but good anti-fungal activity against
C. albicans and A. fumigatus. Dereplication of the medium-
scale extracts pointed to the presence of several bioactive
diketopiperazines, the plant hormone IAA and some unidentified
molecules (Table 5). The diketopiperazine cyclo(prolyltyrosyl)
in the form of (3S, 8aS) can have antibacterial and cytotoxic
effects (Bycroft et al., 1988). Cyclo(phenylalanylprolyl) can
show different configurations, with one configuration (3R, 8aS)
showing some phytotoxic activity and another (3S, 8aS) showing
broad antibacterial activity and gastrointestinal cell maturation
enhancing activity (Blunt and Munro, 2008). Cyclo(prolylvalyl) is
an diketopiperazine antibiotic, with a wide spectrum of activity,
with the form (3R, 8aR) active against Vibrio anguillarum
and the (3S, 8aS) showing a broad antibacterial spectrum
(Bycroft et al., 1988). In fact, Dermacoccus sp. strain #91_17
demonstrated activity against V. anguillarum in a previous study
(Graca et al., 2015).
Gordonia sp. Berg02-22.2 and Gordonia terrae Berg02-78
possess at least one PKS-I gene and showed activity against
Bacillus subtilis in the previous studies (Graca et al., 2013).
Neither Gordonia did show any activity against any of the Gram-
positive strains tested in our study (although B. subtilis was
not tested) but, instead, displayed activity against A. fumigatus
(Table 3). However, antifungal activity of EPA extracts from
Berg02-22.2 and Berg02-78 was not observed. Different culture
conditions such as the ones in Duetz and EPA can influence the
production of bioactive metabolites (Wei et al., 2010). Yet, special
relevance can be attributed to strain Berg02-22.2, as these extracts
demonstrated anti parasitic and several different anti-cancer
activities. Several bioactive capacities of Gordonia spp. were
referred by Sowani et al. (2018), namely a great antimicrobial
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TABLE 6 | Summarized results from the work.
Lipid assay Bioctive Duetz Bioctive EPA Detected components in bioactive
Strain Afiliation activity extracts extracts EPA extracts
Extract Bioactivity Extract Bioactivity
#91_17 Dermacoccus sp. −43% CGY AF CGY AF; CA Cyclo(prolyltyrosyl), cyclo([iso]leucylprolyl),
cyclo(phenylalanylprolyl), cyclo(prolylvalyl),
1H-Indole-3-acetic acid, C41H60N2O9 and
C43H64N2O9
IN-CRY
M016 M016 AF; CA Cyclo(prolyltyrosyl), cyclo([iso]leucylprolyl),
cyclo(phenylalanylprolyl), cyclo(prolylvalyl),
1H-Indole-3-acetic acid, C22H38N4O5 and
C22H21N3O3
Berg02-22.2 Gordonia sp. NA AB AF AB TC Cyclo([iso]leucylprolyl), cyclo(phenylalanylprolyl),
C52H74N10O11, C35H28N6O8,
C28H41N5O10, the peptide
Gly-Pro-Phe-Pro-Ile, nocardichelin A,
nocardichelin B and C42H69N5O8
A2058
HepG2
IN-CRY HepG2 HT29
MCF7
MIAPaCa-2
Berg02-78 Gordonia terrae NA AB AF N/T N/T
IN-CRY TC
#91_29 Microbacterium foliorum 47% NA NA N/T
#91_40 Microbacterium foliorum 50% IN-CRY HepG2 N/T N/T
Berg02-79 Microbacterium sp. NA R358 MRSA N/T N/T
IN-CRY HepG2
Berg02-26 Micrococcus luteus NA IN-CRY AF IN-CRY AF Cyclo([iso]leucylprolyl), cyclo(prolyltyrosyl),
C22H21N3O3 and C13H14N2O3R358 CA
AF, A. fumigatus ATCC46645; CA, C. albicans ATCC64124; MRSA, Methicillin-resistant S. aureus MB 5393; TC, T. cruzi Tulahuen C4, N/T, Not tested.
capacity of a strain of G. terrae isolated from a sponge (Elfalah
et al., 2013). Furthermore, Sowani et al. (2018) also reported the
various compounds already known to be produced by Gordonia
genus. These include circumcin A, kurasoin B, soraphinol C;
bendigole A, canthxanthin, c-carotene, glycolipids, peptidolipids,
and exopolysaccharides. Our work also evidenced the anti-
parasitic bioactivity of Gordonia sp. Berg02-22.2 against T. cruzi.
G. terrae was isolated from the gut of a Triatomore sp. (Gumiel
et al., 2015), which is the insect vectors of T. cruzi (Lent and
Wygodzinsky, 1979). This actinobacterium along with other
bacteria present in the gut microbiota of this insect are believed
to play a role in the epidemiology of Chagas disease by competing
with T. cruzi (Gumiel et al., 2015). Moreover, Davila et al. (2011)
showed that immunized rats with G. bronchialis and challenged
with T. cruzi had a reduction of parasitemia in offspring. The
rat’s immunological system was activated with increased levels
of interferons and reduced levels of interleukins. Gordonia is,
thus, a genus with an extensive biotechnological value. The
dereplication of the extract of Gordonia sp. strain Berg02-22.2
points to the presence of both nocardichelin A and B, as well
as a novel nocardichelin. Both nocardichelin A and B were first
isolated from a strain from the genus Nocardia and were shown
to strongly inhibit human cell lines from gastric adenocarcinoma,
breast carcinoma, and hepatocellular carcinoma (Schneider et al.,
2007). The peptide Gly-Pro-Phe-Pro-Ile was also detected. This
peptide is the result of a pancreatic digestion of β-casein and
has been described as a competitive inhibitor for cathepsin B
which is upregulated in some cancers (Lee and Lee, 2000). The
diketopiperazine cyclo(phenylalanylprolyl) was also detected.
Furthermore, components with the formulae C52H74N10O11,
C35H28N6O8, C28H41N5O10 were detected in the extract but are
of an unknown nature.
Species of the genus Microccocus produce pigmented colonies
which are sources of carotenoid pigments. Rostami et al. (2016)
showed that carotenoid pigments produced by Microccocus
roseus proved to have some antioxidant, antitumor and potent
antibacterial activities, in particular against Gram-positive
bacteria. M. luteus has very few genes associated with secondary
metabolism and possesses one of the smallest genomes from
the phylum Actinobacteria, comprised of a single circular
chromosome with 2.5 Mb in size (Young et al., 2010). Bacteria
with genome sizes below 3 Mb usually have fewer or none
secondary metabolism genes, while above 5 Mb, there appears
to exist a linear correlation between genome size and the
presence of these genes (Donadio et al., 2007). This may imply
a reduced capacity for the production of bioactive molecules for
microorganisms like M. luteus. Nevertheless, in both our small-
scale and medium-scale extractions, M. luteus Berg02-26 proved
to produce anti-fungal bioactive molecules and no hepatotoxicity.
The dereplication of the extract pointed to the presence of
one bioactive diketopiperazine, cyclo(prolyltyrosyl). As discussed
above, this diketopiperazine in the form of (3S, 8aS) can have
antibacterial and cytoxic effects. Several unidentified molecules
were also detected, with compound C13H14N2O3 showing a
coincidence with caerulomycin G in the DNP. Caerulomycin
G is a bypridine alkaloids with a range of activities against
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E. coli, Aerobacter aerogenes and C. albicans and cytotoxic activity
against the cell lines HL-60, A549 (Kim, 2013).
The small-scale extracts from Microbacterium sp. strain
Berg02-79 displayed activity against methicillin-resistant
Staphylococcus aureus and in the HepG2 cell line. Previous
studies had shown activity against Bacillus subtilis (Graca et al.,
2013). Curiously, the methicillin-sensitive strain Staphylococcus
aureus was not affected by the extract. However, in the medium-
scale assay no bioactivity was observed. Once again, the culture
conditions may justify this different behavior. Microbacterium
foliorum, strain #91_40, showed only hepatotoxic activity in
the small-scale screening. Additionally, in the zebrafish fat
metabolism assay, the extract from this strain displayed possible
anti-lipid accumulation activity. Similarly, Microbacterium
foliorum strain #91_29 also displayed this activity. The zebrafish
fat metabolism assay was previously used to identify bioactive
compounds from marine fungi and plant polyphenols and has
the advantage to mirror the complexity of a whole small animal
model and to indicate extracts/compounds with physiologically
relevant activities (Noinart et al., 2017; Urbatzka et al., 2018).
Natural products isolated from different organisms from marine
environments were described to have anti-obesity activities
(Castro et al., 2016). Microbacterium strains have already shown
to possess a varied and interesting repertoire of bioactive
secondary metabolites. Microbacterins A and B isolated from
a deep-sea strain of Microbacterium sediminis, are peptaibols that
showed significant inhibitory effects against human tumor cell
lines like HCT-8, Bel-7402, BGC-823, A549, and A2780 (Liu et al.,
2015). Peptaibols are a class of non-ribosomal linear or cyclic
peptides. Additionally, several glycoglycerolipids were isolated
from Microbacterium sp., and the glycoglycerol GGL.2 showed
promising antitumor activities (Wicke et al., 2000).
As the Duetz extraction requires only a very small volume
of culture, a great variety of growth conditions could be tested.
From the 10 media used for culturing the Actinomycetales,
only extracts from 5 media were bioactive but differently for
each strain. These five media (AB, CGY, IN-CRY, M016, and
R358) all have very different composition. With strain #91-17,
media CGY, IN-CRY, and M016 were the ones that induced
more bioactivities. For strain #91-40 it was medium IN-CRY.
Berg02-22.2 and Berg02-78 had better secondary metabolite
production in media AB and IN-CRY while Berg02-26 and
Berg02-79 the production was favored by media IN-CRY and
R358. Remarkably, in the maintenance medium (Marine Broth)
no bacterium showed bioactivity. These results give further
support to the fact that medium composition is crucial for
the activation of the metabolic pathways to produce secondary
metabolites. Furthermore, the results obtained illustrated quite
well the extended biosynthetic potential of single strains through
the “One strain/many compounds” approach (Wei et al., 2010).
The dereplication of our extracts revealed the complexity
of molecules possibly produced by the bacterial strains.
This molecular diversity can justify the various bioactivities
(antifungal, anti-cancer, anti-parasitic, and anti-obesity)
obtained. Many of the detected molecules likely possess
already known bioactivity. This is the case of molecules like
nocardichelins, diketopiperazines, and bipyridine alkaloids.
Additionally, eight non-identified compounds were also detected.
The variety of components encountered proves that the
Actinomycetales tested are prolific biosynthesizers, reinforcing
the bioactive characteristics of this group.
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